8 research outputs found

    Adaptación psicosocial del paciente oncológico ingresado y del familiar cuidador principal

    Get PDF
    The present study looks for the relation between the psychosocial distress experienced by the patient and his family caregiver during the period he is hospitalised. The sample is composed by 94 persons (oncology patients and family caregivers). We have used a sociodemographic questionnaire, the Hospital Anxiety and Depression Scale, the “Quality of life Questionnaire” for general satisfaction and social support and the family APGAR for family functioning. The results indicate that the anxiety of the caregiver is significantly higher than the one of the patient. The family functioning perceived by the patient correlates negatively with the depression and positively with the general satisfaction of the family caregiver. We found a correlation between the age and the depression subscale. In the family caregivers group we confirm that the higher scores in depression appear in ages between 35 and 55. Married patients and caregivers obtain higher punctuation in depression compared to unmarried ones. We conclude that the patients psychosocial distress differs from the caregivers distress. The psychological intervention should focus on the individual needs of the patient and the caregiver by promoting the social net of the relatives, supplying a better communication with the patient, reducing the caregivers anxiety and attending the demands derived from physical condition, marital status and age

    Adaptación psicosocial del paciente oncológico ingresado y del familiar cuidador principal

    Get PDF
    The present study looks for the relation between the psychosocial distress experienced by the patient and his family caregiver during the period he is hospitalised. The sample is composed by 94 persons (oncology patients and family caregivers). We have used a sociodemographic questionnaire, the Hospital Anxiety and Depression Scale, the “Quality of life Questionnaire” for general satisfaction and social support and the family APGAR for family functioning. The results indicate that the anxiety of the caregiver is significantly higher than the one of the patient. The family functioning perceived by the patient correlates negatively with the depression and positively with the general satisfaction of the family caregiver. We found a correlation between the age and the depression subscale. In the family caregivers group we confirm that the higher scores in depression appear in ages between 35 and 55. Married patients and caregivers obtain higher punctuation in depression compared to unmarried ones. We conclude that the patients psychosocial distress differs from the caregivers distress. The psychological intervention should focus on the individual needs of the patient and the caregiver by promoting the social net of the relatives, supplying a better communication with the patient, reducing the caregivers anxiety and attending the demands derived from physical condition, marital status and age

    Phosphoproteomic Analysis of Platelets in Severe Obesity Uncovers Platelet Reactivity and Signaling Pathways Alterations

    Get PDF
    OBJECTIVE: Obesity is associated with a proinflammatory and prothrombotic state that supports atherosclerosis progression. The goal of this study was to gain insights into the phosphorylation events related to platelet reactivity in obesity and identify platelet biomarkers and altered activation pathways in this clinical condition. APPROACH AND RESULTS: We performed a comparative phosphoproteomic analysis of resting platelets from obese patients and their age- A nd gender-matched lean controls. The phosphoproteomic data were validated by mechanistic, functional, and biochemical assays. We identified 220 differentially regulated phosphopeptides, from at least 175 proteins; interestingly, all were up-regulated in obesity. Most of the altered phosphoproteins are involved in SFKs (Src-family kinases)-related signaling pathways, cytoskeleton reorganization, and vesicle transport, some of them validated by targeted mass spectrometry. To confirm platelet dysfunction, flow cytometry assays were performed in whole blood indicating higher surface levels of GP (glycoprotein) VI and CLEC (C-type lectin-like receptor) 2 in platelets from obese patients correlating positively with body mass index. Receiver operator characteristics curves analysis suggested a much higher sensitivity for GPVI to discriminate between obese and lean individuals. Indeed, we also found that obese platelets displayed more adhesion to collagen-coated plates. In line with the above data, soluble GPVI levels-indicative of higher GPVI signaling activation-were almost double in plasma from obese patients. CONCLUSIONS: Our results provide novel information on platelet phosphorylation changes related to obesity, revealing the impact of this chronic pathology on platelet reactivity and pointing towards the main signaling pathways dysregulatedThis work was supported by the Spanish Ministry of Science and Innovation (grants No. SAF2016-79662-R, and PID2019-108727RB-I00), co-funded by the European Regional Development Fund (ERDF). Financial support from the Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia (Centro Singular de investigación de Galicia accreditation 2019–2022, ED431G 2019/02; predoctoral grant 2018 Call) and the ERDF is also gratefully acknowledged. E.E. Gardiner and R.K. Andrews are supported by the National Health and Medical Research Council of Australia. The Proteomics Laboratory CSIC/UAB (Centro Superior de Investigaciones Científicas/Universidad Autónoma de Barcelona) is a member of Proteored, PRB3-ISCIII (Instituto de Salud Carlos III), and is supported by Grant PT17/0019/0008, funded by ISCIII and ERDF. L.A. Morán is supported by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766118. S.P. Watson is supported by a BHF (British Heart Foundation) Chair (CH03/003)

    A Comprehensive Tyrosine Phosphoproteomic Analysis Reveals Novel Components of the Platelet CLEC-2 Signaling Cascade

    Get PDF
    This is an Accepted Manuscript of an article published by Thieme Publishing Group in Thrombosis and Haemostasis on 04 January 2020, available online at https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0039-3400295C-type lectin-like receptor 2 (CLEC-2) plays a crucial role in different platelet-related physiological and pathological processes. It signals through a tyrosine kinase-mediated pathway that is highly dependent on the positive feedback exerted by the platelet-derived secondary mediators, adenosine diphosphate (ADP) and thromboxane A2 (TXA2). Here, we aimed to analyze the tyrosine phosphoproteome of platelets activated with the CLEC-2 agonist rhodocytin to identify relevant phosphorylated tyrosine residues (p-Tyr) and proteins involved in platelet activation downstream of this receptor. We identified 363 differentially p-Tyr residues, corresponding to the majority of proteins previously known to participate in CLEC-2 signaling and also novel ones, including adaptors (e.g., DAPP1, Dok1/3, CASS4, Nck1/2), kinases/phosphatases (e.g., FAK1, FES, FGR, JAK2, SHIP2), and membrane proteins (e.g., G6F, JAM-A, PECAM-1, TLT-1). To elucidate the contribution of ADP and TXA2 at different points of the CLEC-2 signaling cascade, we evaluated p-Tyr levels of residues identified in the analysis and known to be essential for the catalytic activity of kinases Syk(p-Tyr525+526) and Src(p-Tyr419), and for PLCγ2 activity (p-Tyr759). We demonstrated that Syk phosphorylation at Tyr525+526 also happens in the presence of ADP and TXA2 inhibitors, which is not the case for Src-pTyr419 and PLCγ2-pTyr759. Kinetics studies for the three phosphoproteins show some differences in the phosphorylation profile. Ca2+ mobilization assays confirmed the relevance of ADP and TXA2 for full CLEC-2-mediated platelet activation. The present study provides significant insights into the intracellular events that take place following CLEC-2 activation in platelets, contributing to elucidate in detail the CLEC-2 signalosomeThis study was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) [grant No. SAF2016-79662-R], co-funded by the European Regional Development Fund (ERDF); and the Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia [ED431C 2018/21; predoctoral grant Plan I2C 2014; and Centro Singular de investigación de Galicia accreditation 2016-2019, ED431G/05], co-funded by the European Regional Development Fund (ERDF). The study also received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766118. J.A.E. is supported by Deutsche Forschungsgemeinschaft [DFG grant: EB177/13-1]S

    Abstracts from the Food Allergy and Anaphylaxis Meeting 2016

    Get PDF

    Adaptación psicosocial del paciente oncológico ingresado y del familiar cuidador principal

    No full text
    El presente estudio refleja la relación existente entre la adaptación psicosocial del paciente oncológico y su familiar (cuidador principal) en situación de ingreso. La muestra recogida es de 94 personas (pacientes oncológicos y familiares). Se utilizaron un cuestionario sociodemográfico y clínico; la escala de Ansiedad y Depresión Hospitalaria (HAD) para medir ansiedad y depresión; el Cuestionario de Calidad de vida (CCV) que mide satisfacción general y apoyo social y el APGAR familiar para medir el funcionamiento familiar. Los resultados indican que la ansiedad del familiar es significativamente superior a la del paciente. El funcionamiento familiar percibido por el paciente correlaciona negativamente con la depresión del familiar, con la puntuación total de la escala y positivamente con la subescala de satisfacción general del familiar. A mayor edad del paciente se observan puntuaciones mas elevadas en la subescala de depresión y en el total de la escala del HAD. Los familiares con edades comprendidas entre 35 y 55 años obtienen puntuaciones significativamente superiores en depresion. Tanto los pacientes como los familiares casados presentan niveles significativamente superiores de depresión que los solteros. Con todo esto concluimos que la adaptación psicosocial del paciente y del familiar es diferente por ello la intervención psicológica durante el ingreso debería centrarse en atender conjunta e individualmente las necesidades del paciente y el familiar: fomentando las redes de apoyo del familiar, facilitando una mejor comunicación con el paciente, reduciendo la ansiedad del familiar y atendiendo a las necesidades físicas, edad y estado civil del paciente.The present study looks for the relation between the psychosocial distress experienced by the patient and his family caregiver during the period he is hospitalised. The sample is composed by 94 persons (oncology patients and family caregivers). We have used a sociodemographic questionnaire, the Hospital Anxiety and Depression Scale, the "Quality of life Questionnaire" for general satisfaction and social support and the family APGAR for family functioning. The results indicate that the anxiety of the caregiver is significantly higher than the one of the patient. The family functioning perceived by the patient correlates negatively with the depression and positively with the general satisfaction of the family caregiver. We found a correlation between the age and the depression subscale. In the family caregivers group we confirm that the higher scores in depression appear in ages between 35 and 55. Married patients and caregivers obtain higher punctuation in depression compared to unmarried ones. We conclude that the patients psychosocial distress differs from the caregivers distress. The psychological intervention should focus on the individual needs of the patient and the caregiver by promoting the social net of the relatives, supplying a better communication with the patient, reducing the caregivers anxiety and attending the demands derived from physical condition, marital status and ag

    Platelet membrane lipid rafts protein composition varies following GPVI and CLEC-2 receptors activation

    No full text
    Lipid rafts are membrane microdomains that have been proposed to play an important role in several platelet-signalling cascades, including those mediated by the receptors Glycoprotein VI (GPVI), and C-type lectin domain family 1 member B (CLEC-2), both involved in thrombus formation. We have performed a LC-MS/MS proteomic analysis of lipid rafts isolated from platelets activated through GPVI and CLEC-2 as well as from resting platelets. Our aim was to determine the magnitude of changes in lipid rafts protein composition and to elucidate the relevance of these alterations in platelet function. A number of relevant signalling proteins were found enriched in lipid rafts following platelet activation (such as the tyrosine protein kinases Fyn, Lyn and Yes; the G proteins G(i) and G(z); and cAMP protein kinase). Interestingly, our results indicate that the relative enrichment of lipid rafts in these signalling proteins may not be a consequence of protein translocation to these domains upon platelet stimulation, but the result of a massive loss in cytoskeletal proteins after platelet activation. Thus, this study may help to better understand the effects of platelet activation in the reorganization of lipid rafts and set the basis for further proteomic studies of these membrane microdomains in platelets. Significance: We performed the first proteomic comparative analysis of lipid rafts- protein composition in platelets activated through GPVI and CLEC-2 receptors and in resting state. We identified a number of signalling proteins essential for platelet activation relatively enriched in platelets activated through both receptors, and we show that lipid rafts reorganization upon platelet activation leads to a loss in cytoskeletal proteins, highly associated to these domains in resting platelets.This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) [grant No. SAF2016-79662-R], co-funded by the European Regional Development Fund (ERDF); the Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia [predoctoral grant Plan I2C 2014; and Centro Singular de investigación de Galicia accreditation 2016–2019, ED431G/05; both co-funded by the ERDF]. J.A.E. is supported by Deutsche Forschungsgemeinschat [DFG grant: EB177/13-1]

    A Combination of Proteomic Approaches Identifies A Panel of Circulating Extracellular Vesicle Proteins Related to the Risk of Suffering Cardiovascular Disease in Obese Patients

    No full text
    Plasma-derived extracellular vesicles (EVs) have been extensively described as putative biomarkers in different diseases. Interestingly, increased levels of EVs subpopulations are well known to associate with obesity. The goal of this study is to identify EVs-derived biomarkers in plasma from obese patients in order to predict the development of pathological events associated with obesity. Samples are obtained from 22 obese patients and their lean-matched controls are divided into two cohorts: one for a 2D fluorescence difference gel electrophoresis (2D-DIGE)-based study, and the other one for a label free LC–MS/MS-based approach. EVs are isolated following a serial ultracentrifugation protocol. Twenty-two and 23 differentially regulated features are detected from 2D-DIGE and label free LC–MS/MS, respectively; most of them involve in the coagulation and complement cascades. Remarkably, there is an upregulation of complement C4, complement C3, and fibrinogen in obese patients following both approaches, the latter two also validated by 2D-western-blotting in an independent cohort. These results correlate with a proinflammatory and prothrombotic state of those individuals. On the other hand, a downregulation of adiponectin leading to an increased risk of suffering cardiovascular diseases has been shown. The results suggest the relevance of plasma-derived-EVs proteins as a source of potential biomarkers for the development of atherothrombotic events in obesity.This work was supported by the Spanish Ministry of Economy and Competitiveness; grant No. SAF2016-79662-R), co-funded by the European Regional Development Fund. Financial support from the Conseller ́ıa de Cultura, Educaci ́on e Ordenaci ́on Universitaria, Xunta de Galicia (Centro Singular de investigaci ́on de Galicia accreditation 2016–2019,ED431G/05), and the European Regional Development Fund is also grate-fully acknowledged. The Proteomics Laboratory CSIC/UAB is a member ofProteored, PRB2-ISCIII and is supported by Grant PT13/0001, of the PEI+D+i 2013–2016, funded by ISCIII and FEDER
    corecore